{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:31Z","timestamp":1782722731382,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50753-2","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:07:10Z","timestamp":1777378030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of combining acetazolamide with loop diuretics versus double dose loop diuretics for decongestion in patients with chronic kidney disease: a randomized controlled trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2905-4561","authenticated-orcid":false,"given":"Jiranat","family":"Sriswasdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnart","family":"Chaiprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouppatham","family":"Supasyndh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bancha","family":"Satirapoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"50753_CR1","doi-asserted-by":"publisher","unstructured":"House, A. A. et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 95, 1304\u20131317. https:\/\/doi.org\/10.1016\/j.kint.2019.02.022 (2019).","DOI":"10.1016\/j.kint.2019.02.022"},{"key":"50753_CR2","doi-asserted-by":"publisher","unstructured":"Hung, S. C., Lai, Y. S., Kuo, K. L. & Tarng, D. C. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J. Am. Heart Assoc. 4 https:\/\/doi.org\/10.1161\/jaha.115.001918 (2015).","DOI":"10.1161\/jaha.115.001918"},{"key":"50753_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ki.2013.336","volume":"85","author":"SC Hung","year":"2014","unstructured":"Hung, S. C. et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 85, 703\u2013709. https:\/\/doi.org\/10.1038\/ki.2013.336 (2014).","journal-title":"Kidney Int."},{"key":"50753_CR4","doi-asserted-by":"publisher","unstructured":"McDonagh, T. A. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42, 3599\u20133726 (2021). (2021). https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"50753_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/circheartfailure.112.969246","volume":"6","author":"RD Kociol","year":"2013","unstructured":"Kociol, R. D. et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ. Heart Fail. 6, 240\u2013245. https:\/\/doi.org\/10.1161\/circheartfailure.112.969246 (2013).","journal-title":"Circ. Heart Fail."},{"key":"50753_CR6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2215\/cjn.0000000000000188","volume":"18","author":"A Kazory","year":"2023","unstructured":"Kazory, A. Combination Diuretic Therapy to Counter Renal Sodium Avidity in Acute Heart Failure: Trials and Tribulations. Clin. J. Am. Soc. Nephrol. 18, 1372\u20131381. https:\/\/doi.org\/10.2215\/cjn.0000000000000188 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"50753_CR7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","volume":"97","author":"S Eshaghian","year":"2006","unstructured":"Eshaghian, S., Horwich, T. B. & Fonarow, G. C. Relation of loop diuretic dose to mortality in advanced heart failure. Am. J. Cardiol. 97, 1759\u20131764. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.072 (2006).","journal-title":"Am. J. Cardiol."},{"key":"50753_CR8","doi-asserted-by":"publisher","unstructured":"Sabina, M., Barakat, Z., Feliciano, A., Lamb, A. & Alsamman, M. M. Unlocking the Potential of Acetazolamide: A Literature Review of an Adjunctive Approach in Heart Failure Management. J. Clin. Med. 13 https:\/\/doi.org\/10.3390\/jcm13010288 (2024).","DOI":"10.3390\/jcm13010288"},{"key":"50753_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens, W. et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N Engl. J. Med. 387, 1185\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2203094 (2022).","journal-title":"N Engl. J. Med."},{"key":"50753_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1088\/0967-3334\/27\/9\/012","volume":"27","author":"UM Moissl","year":"2006","unstructured":"Moissl, U. M. et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol. Meas. 27, 921\u2013933. https:\/\/doi.org\/10.1088\/0967-3334\/27\/9\/012 (2006).","journal-title":"Physiol. Meas."},{"key":"50753_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","volume":"37","author":"T Imiela","year":"2017","unstructured":"Imiela, T. & Budaj, A. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. Clin. Drug Investig. 37, 1175\u20131181. https:\/\/doi.org\/10.1007\/s40261-017-0577-1 (2017).","journal-title":"Clin. Drug Investig"},{"key":"50753_CR12","doi-asserted-by":"publisher","first-page":"114058","DOI":"10.1016\/j.biopha.2022.114058","volume":"157","author":"L Guo","year":"2023","unstructured":"Guo, L. et al. Diuretic resistance in patients with kidney disease: Challenges and opportunities. Biomed. Pharmacother. 157, 114058. https:\/\/doi.org\/10.1016\/j.biopha.2022.114058 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"50753_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40256-024-00633-9","volume":"24","author":"AK Siddiqi","year":"2024","unstructured":"Siddiqi, A. K. et al. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. Am. J. Cardiovasc. Drugs. 24, 273\u2013284. https:\/\/doi.org\/10.1007\/s40256-024-00633-9 (2024).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"50753_CR14","doi-asserted-by":"publisher","first-page":"636718","DOI":"10.3389\/fcvm.2021.636718","volume":"8","author":"AJ Accardi","year":"2021","unstructured":"Accardi, A. J., Matsubara, B. S., Gaw, R. L., Daleiden-Burns, A. & Heywood, J. T. Clinical Utility of Fluid Volume Assessment in Heart Failure Patients Using Bioimpedance Spectroscopy. Front. Cardiovasc. Med. 8, 636718. https:\/\/doi.org\/10.3389\/fcvm.2021.636718 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"50753_CR15","unstructured":"Brinkman, J. E., Dorius, B. & Sharma, S. in StatPearls (StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC., (2024)."},{"key":"50753_CR16","doi-asserted-by":"publisher","unstructured":"Kosiorek, A. et al. Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study. Pol. Arch. Intern. Med. 133 https:\/\/doi.org\/10.20452\/pamw.16526 (2023).","DOI":"10.20452\/pamw.16526"},{"key":"50753_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.ekir.2020.06.031","volume":"5","author":"T Yamada","year":"2020","unstructured":"Yamada, T. et al. Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure. Kidney Int. Rep. 5, 1486\u20131494. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.031 (2020).","journal-title":"Kidney Int. Rep."},{"key":"50753_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.repc.2017.10.015","volume":"37","author":"JL Martins","year":"2018","unstructured":"Martins, J. L., Santos, L., Faustino, A., Viana, J. & Santos, J. Worsening or \u2018pseudo-worsening\u2019 renal function? The prognostic value of hemoconcentration in patients admitted with acute heart failure. Rev. Port Cardiol. (Engl Ed). 37, 595\u2013602. https:\/\/doi.org\/10.1016\/j.repc.2017.10.015 (2018).","journal-title":"Rev. Port Cardiol. (Engl Ed)"},{"key":"50753_CR19","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s00380-019-01433-x","volume":"34","author":"H Kataoka","year":"2019","unstructured":"Kataoka, H. Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the \u2018chloride theory\u2019 for heart failure pathophysiology. Heart Vessels. 34, 1952\u20131960. https:\/\/doi.org\/10.1007\/s00380-019-01433-x (2019).","journal-title":"Heart Vessels"},{"key":"50753_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/cs0940287","volume":"94","author":"NR Loon","year":"1998","unstructured":"Loon, N. R. & Wilcox, C. S. Mild metabolic alkalosis impairs the natriuretic response to bumetanide in normal human subjects. Clin. Sci. (Lond). 94, 287\u2013292. https:\/\/doi.org\/10.1042\/cs0940287 (1998).","journal-title":"Clin. Sci. (Lond)"},{"key":"50753_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"Herrington, W. G. et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl. J. Med. 388, 117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233 (2023).","journal-title":"N Engl. J. Med."},{"key":"50753_CR22","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl. J. Med. 383, 1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816 (2020).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50753-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:06:56Z","timestamp":1782720416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50753-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50753-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"29\/3\/2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Date of first registration"}},{"value":"466e6e75-277b-4a98-a711-9fafd97af6fd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Submission ID"}},{"value":"The study was approved by the Ethics Committee of the Institute Review Board at the Royal Thai Army Medical Department and was conducted according to the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"19720"}}